blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1519753

EP1519753 - PHARMACEUTICAL COMBINATION OF A THROMBOXANE A2 RECEPTOR ANTAGONIST AND A COX-2 INHIBITOR [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  01.08.2008
Database last updated on 17.09.2024
Most recent event   Tooltip01.08.2008Refusal of applicationpublished on 03.09.2008  [2008/36]
Applicant(s)For all designated states
B.M.R.A. CORPORATION B.V.
Zeemansstraat 13
3016 CN Rotterdam / NL
[2005/14]
Inventor(s)01 / BRUNNER, Hans, R.
Avenue de Belmont 1
CH-1009 Pully VD / CH
 [2005/14]
Representative(s)Perry, Robert Edward
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London
EC2A 2ES / GB
[N/P]
Former [2005/14]Perry, Robert Edward
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Application number, filing date03738386.603.07.2003
[2005/14]
WO2003IB02633
Priority number, dateUS20020394268P09.07.2002         Original published format: US 394268 P
[2005/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004004776
Date:15.01.2004
Language:EN
[2004/03]
Type: A1 Application with search report 
No.:EP1519753
Date:06.04.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 15.01.2004 takes the place of the publication of the European patent application.
[2005/14]
Search report(s)International search report - published on:EP15.01.2004
ClassificationIPC:A61K45/06, A61P9/10, A61P19/02, A61K31/42, A61K31/415
[2005/14]
CPC:
A61K45/06 (EP,US); A61K31/18 (EP,US); A61K31/19 (EP,US);
A61K31/415 (EP,US); A61K31/42 (EP,US); A61K31/557 (EP,US);
A61P19/02 (EP); A61P25/04 (EP); A61P29/00 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61P9/10 (EP);
A61P9/12 (EP) (-)
C-Set:
A61K31/18, A61K2300/00 (EP,US);
A61K31/19, A61K2300/00 (US,EP);
A61K31/415, A61K2300/00 (US,EP);
A61K31/42, A61K2300/00 (US,EP);
A61K31/557, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/14]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:KOMBINATIONSZUSAMMENSETZUNG VON EINEM THROMBOXAN-A2-REZEPTOR ANTAGONIST UND EINEM CYCLOOXYGENASE-2 HEMMER[2005/14]
English:PHARMACEUTICAL COMBINATION OF A THROMBOXANE A2 RECEPTOR ANTAGONIST AND A COX-2 INHIBITOR[2005/14]
French:COMBINAISON PHARMACEUTIQUE D'UN ANTAGONISTE DU RECEPTEUR DE LA THROMBOXANE A2 ET D'UN INHIBITEUR DU COX-2[2005/14]
Entry into regional phase26.01.2005National basic fee paid 
26.01.2005Designation fee(s) paid 
26.01.2005Examination fee paid 
Examination procedure02.02.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.12.2004Amendment by applicant (claims and/or description)
26.01.2005Examination requested  [2005/14]
02.08.2006Despatch of a communication from the examining division (Time limit: M04)
01.12.2006Reply to a communication from the examining division
06.06.2007Despatch of a communication from the examining division (Time limit: M04)
04.10.2007Reply to a communication from the examining division
07.04.2008Cancellation of oral proceeding that was planned for 24.06.2008
07.04.2008Minutes of oral proceedings despatched
14.04.2008Despatch of communication that the application is refused, reason: substantive examination [2008/36]
24.04.2008Application refused, date of legal effect [2008/36]
24.06.2008Date of oral proceedings
24.06.2008Date of oral proceedings (cancelled)
Fees paidRenewal fee
13.07.2005Renewal fee patent year 03
12.07.2006Renewal fee patent year 04
13.07.2007Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0187343  (MERCK FROSST CANADA INC [CA], et al) [X] 1-29 * page 3, line 1 - line 6 * * page 3, line 14 - line 15 * * page 4, line 22 - line 24 ** page 16, line 15 - line 18; examples 1-7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.